Hasten

Recent Finacing

Equity

Recent Raise

$315M

Hasten is a pharmaceutical company building a platform and late-stage pipeline, acquiring Chinese mainland exclusive rights to cardiovascular and metabolic drugs, serving chronic, age-related, acute and severe disease patients.